Jaguar Animal Health Inc (NASDAQ:JAGX) — Market Cap & Net Worth
Market Cap & Net Worth: Jaguar Animal Health Inc (JAGX)
Jaguar Animal Health Inc (NASDAQ:JAGX) has a market capitalization of $1.89 Million ($1.89 Million) as of September 25, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30166 globally and #6134 in its home market, demonstrating a 2113.17% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jaguar Animal Health Inc's stock price $7.06 by its total outstanding shares 5168300 (5.17 Million). Also see JAGX asset base for a full breakdown of the balance sheet.
Jaguar Animal Health Inc Market Cap History: 2015 to 2026
Jaguar Animal Health Inc's market capitalization history from 2015 to 2026. Data shows change from $5.17 Trillion to $36.49 Million (-66.18% CAGR). Also see Jaguar Animal Health Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Jaguar Animal Health Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.64 Trillion | 0.00% | #881 of 976 |
|
NASDAQ Composite
IXIC
|
$42.16 Trillion | 0.00% | #2811 of 3165 |
Weight: Jaguar Animal Health Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Jaguar Animal Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jaguar Animal Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Jaguar Animal Health Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.42x
Jaguar Animal Health Inc's market cap is 0.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.17 Trillion | $141.52K | -$14.73 Million | 36519152.36x | N/A |
| 2017 | $5.17 Trillion | $4.36 Million | -$21.97 Million | 1185067.55x | N/A |
| 2018 | $1.12 Trillion | $4.42 Million | -$32.15 Million | 253262.96x | N/A |
| 2019 | $55.89 Billion | $5.78 Million | -$38.54 Million | 9677.47x | N/A |
| 2020 | $56.86 Billion | $9.38 Million | -$33.81 Million | 6059.05x | N/A |
| 2021 | $24.19 Billion | $4.33 Million | -$52.59 Million | 5579.62x | N/A |
| 2022 | $2.02 Billion | $11.96 Million | -$47.45 Million | 169.24x | N/A |
| 2023 | $46.82 Million | $9.76 Million | -$41.30 Million | 4.80x | N/A |
| 2024 | $5.22 Million | $11.69 Million | -$38.49 Million | 0.45x | N/A |
| 2025 | $4.81 Million | $11.51 Million | -$53.43 Million | 0.42x | N/A |
Competitor Companies of JAGX by Market Capitalization
Companies near Jaguar Animal Health Inc in the global market cap rankings as of September 25, 2026. Review JAGX intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Jaguar Animal Health Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #333 globally with a market cap of $80.46 Billion USD.
- CSL Ltd (AU:CSL): Ranked #450 globally with a market cap of $61.49 Billion USD ( AU$86.90 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $522.38 |
| #333 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $80.46 Billion | $796.02 |
| #450 | CSL Ltd | AU:CSL | $61.49 Billion | AU$179.12 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $194.82 |
Jaguar Animal Health Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Jaguar Animal Health Inc's market cap moved from $5.17 Trillion to $ 36.49 Million, with a yearly change of -66.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $36.49 Million | +658.16% |
| 2025 | $4.81 Million | -7.80% |
| 2024 | $5.22 Million | -88.85% |
| 2023 | $46.82 Million | -97.69% |
| 2022 | $2.02 Billion | -91.63% |
| 2021 | $24.19 Billion | -57.46% |
| 2020 | $56.86 Billion | +1.75% |
| 2019 | $55.89 Billion | -95.00% |
| 2018 | $1.12 Trillion | -78.36% |
| 2017 | $5.17 Trillion | 0.00% |
| 2016 | $5.17 Trillion | 0.00% |
| 2015 | $5.17 Trillion | -- |
End of Day Market Cap According to Different Sources
On Sep 25th, 2026 the market cap of Jaguar Animal Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.89 Million USD |
| MoneyControl | $1.89 Million USD |
| MarketWatch | $1.89 Million USD |
| marketcap.company | $1.89 Million USD |
| Reuters | $1.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. I… Read more